首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Comparison of Tc-99m-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy
【24h】

Comparison of Tc-99m-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy

机译:TC-99M-Sestamibi分子乳腺成像和乳腺MRI在接受Neoadjuvant化疗的患者中的乳腺MRI

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE. The purpose of this study is to prospectively compare the size of invasive breast cancer before and after neoadjuvant chemotherapy (NAC) at breast MRI and molecular breast imaging (MBI) and to assess the accuracy of post-NAC MBI and MRI relative to pathologic analysis.
机译:客观的。 本研究的目的是在乳腺MRI和分子乳腺成像(MBI)之前先前比较新辅助化疗(NAC)之前和之后的侵入性乳腺癌的大小,并评估NAC后MBI和MRI相对于病理分析的准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号